BBVA(BBVA)

Search documents
X @Bloomberg
Bloomberg· 2025-09-25 07:22
The Spanish securities regulator CNMV gives the green light for the raised $20 billion offer that BBVA has made for rival Banco Sabadell https://t.co/hku0uaOdUS ...
Spain's market supervisor authorises bank BBVA's higher offer for Sabadell
Reuters· 2025-09-25 07:22
Group 1 - The Spanish stock market supervisor has authorized BBVA's improved bid for Sabadell, which amounts to 17 billion euros (approximately $20 billion) [1] - The bid for Sabadell was announced on Monday, indicating a strategic move by BBVA to strengthen its position in the banking sector [1] - This acquisition reflects ongoing consolidation trends within the banking industry in Spain [1]
BBVA raises takeover bid for Banco Sabadell
Yahoo Finance· 2025-09-22 12:28
Spanish bank BBVA has revised its acquisition offer for local peer Banco Sabadell, proposing a 10% increase from its previous offer. The updated offer translates to one new BBVA share for every 4.8376 Banco Sabadell shares. This new all-share offer is designed to be tax neutral for shareholders, provided that more than 50% of Banco Sabadell's voting rights are accepted. In a statement, BBVA said that the new offer values Banco Sabadell shares at €3.39 per share, the highest valuation in over a decade. ...
美股前瞻 | 三大股指期货齐跌,金价再创纪录,本周美联储官员讲话将成市场焦点
智通财经网· 2025-09-22 12:04
Market Overview - US stock index futures are all down ahead of the market opening, with Dow futures down 0.30%, S&P 500 futures down 0.26%, and Nasdaq futures down 0.32% [1] - European indices show mixed results, with Germany's DAX down 0.75%, UK's FTSE 100 up 0.01%, France's CAC40 down 0.32%, and the Euro Stoxx 50 down 0.41% [2][3] - WTI crude oil prices fell by 0.82% to $61.89 per barrel, while Brent crude oil dropped by 0.79% to $66.15 per barrel [4] Federal Reserve and Economic Indicators - The US stock market reached historical highs last week, driven by expectations of interest rate cuts from the Federal Reserve, with key speeches from Fed officials expected this week [5] - The market is closely watching the upcoming inflation data, with expectations that the core PCE price index will show a month-on-month increase of 0.2% and a year-on-year increase of 2.9% [5] Technology Sector Impact - The increase in H-1B visa fees to $100,000 has raised concerns in the tech industry, particularly in California, where companies rely heavily on skilled foreign workers [5] - Despite this, optimism remains in the tech sector, with analysts suggesting that the recent market rally could continue, particularly for large tech stocks [5] Investment Strategies - Goldman Sachs predicts that the Fed's rate cuts will extend the bull market in US stocks, recommending investments in interest-sensitive sectors like real estate and finance [6] - The S&P 500 index is projected to reach 6200 points by the end of 2025, indicating potential for further gains if inflation continues to decline [6] Cryptocurrency Market - The cryptocurrency market faced significant sell-offs, with over $15 billion in long positions liquidated, leading to a drop in total market capitalization below $400 billion [7] - Ethereum and Bitcoin experienced sharp declines, with Ethereum's price dropping nearly 9% at one point [7] Precious Metals - Gold prices reached a new record high of $3728.26 per ounce, driven by rising expectations for interest rate cuts, while silver also saw significant gains, reaching a 14-year high [8] Corporate News - Pfizer announced a $4.9 billion acquisition of Metsera to strengthen its obesity drug pipeline, with a 43% premium over Metsera's last closing price [9][10] - Nvidia partnered with Abu Dhabi's TII to establish the first AI technology center in the Middle East, focusing on next-generation AI models and robotics [10] - Vodafone signed a £2 billion contract with Ericsson and Nokia to expand its network coverage in the UK, addressing the need for revenue in a sluggish mobile market [11] - BBVA increased its offer by 10% to acquire Banco Sabadell, valuing the deal at approximately €17 billion ($20 billion) [12] - Roche's new breast cancer drug showed positive results in a Phase III trial, potentially extending progression-free survival for patients [13] Strategic Focus - HSBC is shifting its strategic focus towards Asia and the Middle East, recognizing the significant capital flow and wealth in these regions [13]
西班牙银行业即将重塑?毕尔巴鄂银行(BBVA.US)最终加价10%收购萨瓦德尔
智通财经网· 2025-09-22 08:55
Group 1 - BBVA has increased its offer to acquire Banco Sabadell by approximately 10%, valuing Sabadell at around €17 billion (approximately $20 billion), which represents a premium of about 1.6% over its market value as of last Friday [1] - The new proposal involves exchanging 4.8376 shares of Sabadell for 1 share of BBVA, marking a shift in BBVA's stance after previously stating it had no intention to raise its offer [1] - Despite Sabadell's decision to sell its UK subsidiary TSB to Santander and distribute a €2.5 billion special dividend, BBVA felt compelled to increase its bid [1] Group 2 - BBVA's previous offer included a combination of stock and cash, which was seen as undervaluing Sabadell, leading to its rejection by Sabadell's board [2] - The all-stock acquisition proposal allows Spanish tax residents to avoid capital gains tax, enhancing the attractiveness of the offer for shareholders [2] - BBVA remains committed to the acquisition despite restrictions imposed by the Spanish government, which limits the integration of Sabadell for several years, potentially delaying cost synergies [2] Group 3 - If the merger is completed, it will create a major player in the Spanish banking sector, with BBVA currently being the second-largest bank by asset size and Sabadell the fourth [2]
BBVA raises bid for Sabadell, now offers 1 BBVA share for 4.8376 shares
Reuters· 2025-09-22 06:01
Spanish bank BBVA on Monday said it raised its bid for rival Sabadell and now offers 1 of its own shares for each 4.8376 Sabadell shares in what would be Spain's second-biggest banking deal by assets. ...
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – GTLS, BBVA, VMEO, and TGNA
Globenewswire· 2025-09-19 21:30
Group 1 - Class Action Attorney Juan Monteverde's firm has recovered millions for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report [1] - Chart Industries, Inc. is under investigation related to its sale to Baker Hughes Co. for $210.00 per share in cash, with a shareholder vote scheduled for October 6, 2025 [1] - Banco Bilbao Vizcaya Argentaria, S.A. is set to acquire Banco de Sabadell, offering one newly issued share and €0.70 in cash for each 5.5483 shares tendered, with the tender offer expiring on October 7, 2025 [2] - Vimeo, Inc. shareholders will receive $7.85 in cash per share in its sale to Bending Spoons US Inc. [3] - TEGNA Inc. shareholders will receive $22.00 per share in cash in its sale to Nexstar Media Group, Inc. [3] Group 2 - Monteverde & Associates PC is a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court [4] - The firm emphasizes that no company, director, or officer is above the law, encouraging shareholders with concerns to reach out for additional information [5]
5 Stocks With High ROE to Buy as Markets Hover Around Record Highs
ZACKS· 2025-09-17 15:15
Market Overview - The broader equity markets have reached all-time highs, driven by optimism regarding a potential interest rate cut by the Federal Reserve despite concerns about the economy and a slowdown in the labor market [1] - The consumer price index increased by 0.4% for the month, surpassing expectations of a 0.3% rise, while only 22,000 jobs were added in August, indicating soft labor market conditions [1] Investment Strategy - Investors are adopting a wait-and-see approach regarding the central bank's monetary policy and its outlook on economic growth and inflation, which may influence future rate cuts [2] - Identifying "cash cow" stocks with high returns is essential, but it must be supported by attractive efficiency ratios like return on equity (ROE) [2][3] Importance of ROE - ROE, calculated as Net Income divided by Shareholders' Equity, helps investors differentiate between profit-generating companies and those that are not, indicating financial health [3] - A higher ROE signifies effective management in generating profits without new equity capital, thus rewarding shareholders with attractive risk-adjusted returns [4] Stock Screening Parameters - Stocks were shortlisted based on criteria including Cash Flow greater than $1 billion and ROE exceeding the industry average [5] - Additional metrics include Price/Cash Flow lower than the industry average, Return on Assets (ROA) greater than the industry average, and 5-Year EPS Historical Growth exceeding the industry average [6][7] Featured Stocks - **Arista Networks Inc. (ANET)**: Engaged in cloud networking solutions with a long-term earnings growth expectation of 18.7% and a trailing four-quarter earnings surprise of 12.8%, holding a Zacks Rank 1 [8][9] - **TE Connectivity plc (TEL)**: A global technology company with a long-term earnings growth expectation of 9.8% and a trailing four-quarter earnings surprise of 4.9%, holding a Zacks Rank 2 [10][11] - **Corning Incorporated (GLW)**: Focused on glass technologies with a long-term earnings growth expectation of 18.2% and a trailing four-quarter earnings surprise of 4.7%, also holding a Zacks Rank 2 [12] - **Banco Bilbao Vizcaya Argentaria, S.A. (BBVA)**: Provides banking services with a long-term earnings growth expectation of 10% and a trailing four-quarter earnings surprise of 7.4%, holding a Zacks Rank 2 [13] - **AppLovin Corporation (APP)**: Offers software solutions for advertisers with a long-term earnings growth expectation of 20% and a trailing four-quarter earnings surprise of 22.4%, holding a Zacks Rank 1 [14]
What Makes Banco Bilbao Vizcaya Argentaria (BBVA) a Potential Investment?
Yahoo Finance· 2025-09-17 13:25
Core Viewpoint - Ariel Investments' "Ariel Global Fund" experienced a +7.38% return in Q2 2025, underperforming compared to the MSCI ACWI Index (+11.53%) and MSCI ACWI Value Index (+5.84%) amid market volatility driven by tariff announcements and AI stock enthusiasm [1] Group 1: Fund Performance - The Ariel Global Fund's performance in Q2 2025 was marked by significant market fluctuations, with stocks initially falling after the "Liberation Day" tariff announcement and then rebounding due to a pause in tariff implementation [1] - The fund's return of +7.38% was lower than the broader market indices, indicating a challenging investment environment [1] Group 2: Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) - BBVA's stock had a one-month return of 1.54% and an impressive 81.97% increase over the last 52 weeks, closing at $19.18 per share with a market capitalization of $110.412 billion on September 16, 2025 [2] - The fund highlighted BBVA's strong market position in Mexico and its growth potential driven by market share gains and favorable demographics in Turkey, alongside the benefits from falling inflation and reduced policy rates [3] - A potential merger between BBVA and Banco Sabadell could unlock significant value through market share gains and cost synergies, despite BBVA's current shares trading at a discount relative to peers [3] Group 3: Hedge Fund Interest - BBVA was held by 10 hedge fund portfolios at the end of Q2 2025, a decrease from 12 in the previous quarter, indicating a decline in popularity among hedge funds [4] - While BBVA is recognized for its investment potential, the company noted that certain AI stocks may offer greater upside potential with less downside risk [4]
Swedish Orphan Biovitrum AB (publ) - Special Call
Seeking Alpha· 2025-09-16 20:43
Group 1 - The company Sobi has received acceptance from the FDA for the filing package related to the NASP program for uncontrolled gout [1] - Dr. Herbert Baraf, a prominent figure in rheumatology, is involved in the discussion, highlighting the clinical expertise supporting the NASP program [2][3] - The NASP program, formerly known as SEL-212, has been under development for over 7 years, indicating a long-term commitment to addressing gout treatment [4]